Raymond James Raises PT on Tenet Healthcare Corporation (THC) to $200 From $185

Tenet Healthcare Corporation (NYSE:THC) is one of the best strong buy healthcare stocks to buy now. On July 23, Raymond James raised the firm’s price target on Tenet Healthcare Corporation (NYSE:THC) to $200 from $185, keeping an Outperform rating on the shares.

Tenet Healthcare Corporation (THC) Has Jim Cramer Seriously Worried Due To Medicaid Cutback

A room full of medical personnel collaborating on a treatment plan for a patient.

The rating update came after Tenet Healthcare Corporation announced its Q2 results on July 22. The analyst told investors in a research note that the company’s Q2 results surpassed expectations, suggesting a strong quarter.

However, James also stated that the stock move after the results was “a bit surprising” and “overdone.”

Tenet Healthcare Corporation reported a 74% increase in adjusted diluted earnings per share to $4.02 in Q2 2025, compared to $2.31 in the same quarter last year. Consolidated adjusted EBITDA for the quarter also rose 18.6% to $1.121 billion compared to Q2 2024.

Management expects the FY 2025 adjusted EBITDA outlook to be in the range of $4.40 billion to $4.54 billion, reflecting a $395 million increase at the midpoint.

Tenet Healthcare Corporation provides healthcare services. The company’s operations are divided into the Hospital Operations and Ambulatory Care segments.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

This article is originally published at Insider Monkey.